Protection against Lethal Leptospirosis after Vaccination with LipL32 Coupled or Coadministered with the B Subunit of Escherichia coli Heat-Labile Enterotoxin

Adler, 2010, Leptospira and leptospirosis, Vet. Microbiol., 140, 287, 10.1016/j.vetmic.2009.03.012

Atzingen, 2010, Characterization of leptospiral proteins that afford partial protection in hamsters against lethal challenge with Leptospira interrogans, J. Med. Microbiol., 59, 1005, 10.1099/jmm.0.021485-0

Branger, 2001, Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination, Infect. Immun., 69, 6831, 10.1128/IAI.69.11.6831-6838.2001

Branger, 2005, Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1, Infect. Immun., 73, 4062, 10.1128/IAI.73.7.4062-4069.2005

Chang, 2007, Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates, Vaccine, 25, 8190, 10.1016/j.vaccine.2007.09.020

Chen, 2009, Amplification of immune responses against a DNA-delivered idiotypic lymphoma antigen by fusion to the B subunit of E. coli heat labile toxin, Vaccine, 27, 4289, 10.1016/j.vaccine.2009.05.025

Cullen, 2002, Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai, Infect. Immun., 70, 2311, 10.1128/IAI.70.5.2311-2318.2002

da Hora, 2011, Non-toxic derivatives of LT as potent adjuvants, Vaccine, 29, 1538, 10.1016/j.vaccine.2010.11.091

da Silva Ramos Rocha, 2008, B subunit of Escherichia coli heat-labile enterotoxin as adjuvant of humoral immune response in recombinant BCG vaccination, Can. J. Microbiol., 54, 677, 10.1139/W08-056

Dellagostin, 2011, Recombinant vaccines against leptospirosis, Hum. Vaccin., 7, 1215, 10.4161/hv.7.11.17944

Felix, 2009, Leptospirosis vaccine: search for subunit candidates, Proc. Vaccinol., 1, 110, 10.1016/j.provac.2009.07.020

Felix, 2011, Subunit approach to evaluation of the immune protective potential of leptospiral antigens, Clin. Vaccine Immunol., 18, 2026, 10.1128/CVI.05297-11

Fernandes, 2007, Monoclonal antibodies against LipL32, the major outer membrane protein of pathogenic Leptospira: production, characterization, and testing in diagnostic applications, Hybridoma (Larchmt.), 26, 35, 10.1089/hyb.2006.033

Fingerut, 2005, Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast, Vaccine, 23, 4685, 10.1016/j.vaccine.2005.03.050

Fingerut, 2006, B subunit of E. coli enterotoxin as adjuvant and carrier in oral and skin vaccination, Vet. Immunol. Immunopathol., 112, 253, 10.1016/j.vetimm.2006.03.005

Fischer, 2007, Immunomodulation produced by a green propolis extract on humoral and cellular responses of mice immunized with SuHV-1, Vaccine, 25, 1250, 10.1016/j.vaccine.2006.10.005

Fraga, 2010, Refolding of the recombinant protein OmpA70 from Leptospira interrogans from inclusion bodies using high hydrostatic pressure and partial characterization of its immunological properties, J. Biotechnol., 148, 156, 10.1016/j.jbiotec.2010.04.007

Haake, 2000, The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection, Infect. Immun., 68, 2276, 10.1128/IAI.68.4.2276-2285.2000

Haake, 2004, Molecular evolution and mosaicism of leptospiral outer membrane proteins involves horizontal DNA transfer, J. Bacteriol., 186, 2818, 10.1128/JB.186.9.2818-2828.2004

Habarta, 2011, Increased immunogenicity to LipL32 of Leptospira interrogans when expressed as a fusion protein with the cholera toxin B subunit, Curr. Microbiol., 62, 526, 10.1007/s00284-010-9739-6

Hartwig, 2010, High yield expression of leptospirosis vaccine candidates LigA and LipL32 in the methylotrophic yeast Pichia pastoris, Microb. Cell Fact., 9, 98, 10.1186/1475-2859-9-98

Hauk, 2009, Structure and calcium-binding activity of LipL32, the major surface antigen of pathogenic Leptospira sp, J. Mol. Biol., 390, 722, 10.1016/j.jmb.2009.05.034

Hoke, 2008, LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata, Infect. Immun., 76, 2063, 10.1128/IAI.01643-07

Jagusztyn-Krynicka, 1993, Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: importance of the linker for antigenicity and biological activities of the hybrid proteins, Infect. Immun., 61, 1004, 10.1128/IAI.61.3.1004-1015.1993

Ko, 2009, Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen, Nat. Rev. Microbiol., 7, 736, 10.1038/nrmicro2208

Lucas, 2011, Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model, Vaccine, 29, 3413, 10.1016/j.vaccine.2011.02.084

Malmstrom, 2009, Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans, Nature, 460, 762, 10.1038/nature08184

Naiman, 2001, Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes, Infect. Immun., 69, 7550, 10.1128/IAI.69.12.7550-7558.2001

Picardeau, 2008, Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis, PLoS One, 3, e1607, 10.1371/journal.pone.0001607

Seixas, 2007, Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge, Vaccine, 26, 88, 10.1016/j.vaccine.2007.10.052

Seixas, 2007, Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis, Can. J. Microbiol., 53, 472, 10.1139/w06-138

Silva, 2007, The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis, Vaccine, 25, 6277, 10.1016/j.vaccine.2007.05.053

Silva, 2008, Characterization of virulence of Leptospira isolates in a hamster model, Vaccine, 26, 3892, 10.1016/j.vaccine.2008.04.085

Tucunduva de Faria, 2007, Morphological alterations in the kidney of rats with natural and experimental Leptospira infection, J. Comp. Pathol., 137, 231, 10.1016/j.jcpa.2007.08.001

Vernel-Pauillac, 2006, Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans, Infect. Immun., 74, 4172, 10.1128/IAI.00447-06

Vivian, 2009, Crystal structure of LipL32, the most abundant surface protein of pathogenic Leptospira spp, J. Mol. Biol., 387, 1229, 10.1016/j.jmb.2009.02.038

Zhou, 2009, Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model, Vaccine, 27, 5013, 10.1016/j.vaccine.2009.05.009

Zuerner, 2011, A Leptospira borgpetersenii serovar Hardjo vaccine induces a Th1 response, activates NK cells, and reduces renal colonization, Clin. Vaccine Immunol., 18, 684, 10.1128/CVI.00288-10